Sponsored
Global Market Expansion: Addressing the Burden in Emerging Economies
How will the rising Parkinson’s prevalence in Asia-Pacific and LATAM drive market volume?
The "Parkinson’s Pandemic" is most evident in rapidly aging and industrializing nations. As access to healthcare improves in these regions, the volume of diagnoses is skyrocketing. This presents a massive opportunity for volume-driven strategies, particularly for high-quality generic versions of standard medications.
How does Parkinson's Therapy Market Access in emerging regions look for 2025?
The main hurdle is Parkinson's Therapy Market Access. In 2024, we are seeing tiered pricing models and local manufacturing partnerships in India and Brazil aimed at making advanced infusion pumps and new-generation MAO-B inhibitors affordable. By 2025, the APAC region is expected to be the fastest-growing geographical segment in terms of units sold.
Telemedicine as a catalyst for market penetration
In regions with few movement disorder specialists, telemedicine is bridging the gap. Digital health platforms allow for remote diagnosis and prescription, effectively expanding the patient pool for pharmaceutical companies. In 2025, we expect "Digital Pharmacies" to play a key role in the distribution of Parkinson’s meds in rural China and Southeast Asia.
|
Region |
2025 Growth Driver |
Market Strategy |
|
Asia-Pacific |
Rapidly aging populations |
Generic-plus and Digital Health |
|
Latin America |
Expanded Insurance Coverage |
Public-Private Partnerships |
|
Middle East/Africa |
Improving Diagnostic Infra |
Education-led market building |
Global Strategy Outlook
For Big Pharma, the 2025 goal is a "Dual-Track" strategy: high-value innovation in Western markets and high-volume, affordable access in emerging economies.
Author: Sofiya Sanjay
Designation: Healthcare Research Consultant, Market Research Future
About: At Market Research Future (MRFR), we enable organizations to unravel complex industries through Cooked Research Reports (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Our studies across products, technologies, applications, end users, and global to country-level segments help decision-makers see more, know more, and do more.
Contact: 99 Hudson Street, 5th Floor, New York, NY 10013, USA | (855) 661-4441 (US) | +44 1720 412 167 (UK) | +91 2269738890 (APAC) | info@marketresearchfuture.com